Visus Therapeutics is a clinical-stage company developing innovative medicines.
Visus Therapeutics is a clinical-stage company developing innovative medicines to improve the vision for people around the world.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 9, 2021 | Series A | $36M | 1 | — | — | Detail |